Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Cerebain Biotech Corp. (OTC: CBBT).

Full DD Report for CBBT

You must become a subscriber to view this report.


Recent News from (OTC: CBBT)

Cerebain's Strategic Partner Adds Key Personnel to Accelerate Advancement of Device Development
Cerebain Biotech (OTCQB: CBBT) today announced that the company’s strategic partner, Sonos Models, Inc., has added key personnel to its staff to facilitate the acceleration in development of the company’s medical device. These additions come as Cerebain readies itself for clini...
Source: Business Wire
Date: March, 16 2018 09:00
Cerebain Biotech to Initiate Search for Contract Research Organization
Cerebain Biotech (OTCQB: CBBT) today announced that the company intends to initiate the search process to partner with a Contract Research Organization (CRO). The search comes as Cerebain readies itself for clinical trials and the FDA application process in conjunction with the development a...
Source: Business Wire
Date: March, 01 2018 12:00
Cerebain Biotech Engages NMS Capital Advisors
Cerebain Biotech Corp. (“Cerebain” or “Company”) (OTCQB: CBBT), a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device to address dementias, and in particular, Alzheimer’s disea...
Source: Business Wire
Date: March, 09 2017 08:30
Cerebain Biotech Engages Biotechnical Engineer
Cerebain Biotech (OTCQB: CBBT) today announced that the company has engaged a Biotechnical Engineer to serve on the corporate team. The engagement comes as Cerebain readies itself for clinical trials and the FDA application process in conjunction with the development and testing of its medic...
Source: Business Wire
Date: February, 13 2017 14:30
Cerebain Biotech Applauds Congressional Passage of 21st Century Cures Act
Cerebain Biotech (OTCQB: CBBT) today applauded the Congressional passage of the 21st Century Cures Act. The law has the potential to invigorate medical research, promote innovation and speed the development of new treatments for Alzheimer’s and other chronic diseases. The Cures Ac...
Source: Business Wire
Date: February, 07 2017 08:31
Cerebain Biotech Presents Update on Its Medical Device Research and Development as It Continues Its Battle against Alzheimer's and Dementia
Cerebain Biotech (OTCQB: CBBT) today announced that the executive team of Cerebain Biotech Corp. is very pleased to provide an update on the progress of its medical device research and development made over the last year and an outlook of 2017. In April 2016, we announced our intention...
Source: Business Wire
Date: September, 13 2016 08:20
Cerebain Biotech and Mossakowski Medical Research Centre Sign Memorandum of Understanding
Cerebain Biotech (OTCQB: CBBT) today announced that they signed a Memorandum of Understanding with the Department of Neurodegenerative Diseases, Mossakowski Medical Research Centre in Poland. The purpose of the Memorandum of Understanding is to commence testing of Cerebain’s Medical D...
Source: Business Wire
Date: June, 23 2016 08:30
Governor Scott McCallum, Representing Cerebain Biotech, to Present at US-Poland Health Care Summit
Cerebain Biotech (OTCQB: CBBT) today announced that Governor Scott McCallum, former governor of Wisconsin, has received an invitation and will be participating in a US-Poland Health Care Summit. The conference will begin on June 17, 2016 and be held in Warsaw, Poland. Governor McCallum w...
Source: Business Wire
Date: June, 01 2016 08:25
Cerebain Biotech Announces Business Relocation into the Heart of Orange County, California
Cerebain Biotech Announces Business Relocation into the Heart of Orange County, California
Source: OTC Markets
Date: May, 04 2016 00:00
CORRECTING and REPLACING Cerebain Biotech Today Announced It Plans to Seek FDA Approval
CORRECTING and REPLACING Cerebain Biotech Today Announced It Plans to Seek FDA Approval
Source: OTC Markets
Date: May, 03 2016 00:00

 


About Cerebain Biotech Corp. (OTC: CBBT)

Logo for Cerebain Biotech Corp. (OTC: CBBT)

Cerebain Biotech Corp. was incorporated on December , under the laws of Nevada. The Company is a smaller reporting biomedical company and through its wholly owned subsidiary, Cerebain Operating, Inc., the Company s business revolves around the discovery of products for the treatment of Alzheimer s disease utilizing Omentum. The Company plans to produce products that will include both a medical device solution as well as a synthetic drug solution.

 

 

 

Current Management

  • Eric Clemons / CEO
  • Wesley Tate / CFO
  • Eric Clemons /
  • Wesley Tate /

Current Share Structure

  • Market Cap: $1,325,902 - 03/09/2018
  • Authorized: 249,000,000 - 02/28/2018
  • Issue and Outstanding: 8,839,347 - 02/28/2018
  • Float: 2,347,210 - 09/27/2016

 


Recent Filings from (OTC: CBBT)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 06 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 09 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: October, 03 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: September, 15 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 11 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 10 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2016
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: October, 24 2016

 

 


Daily Technical Chart for (OTC: CBBT)

Daily Technical Chart for (OTC: CBBT)


Stay tuned for daily updates and more on (OTC: CBBT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CBBT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CBBT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CBBT and does not buy, sell, or trade any shares of CBBT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/